Résumé
The study aimed to investigate the phytochemical profiles, in vitro antioxidant activity, and in silico molecular dockingantidiabetic activity of the aqueous root extracts of Ruellia tuberosa L. The phytochemical qualitative tests revealedthe positive detections of tannins, flavonoids, ascorbic acid, and phenolic compounds. Using Liquid chromatographyhigh-resolution mass spectrometry (LC-HRMS) analysis, 12 compounds were tentatively identified in the extracts.The major compounds were tentatively identified as betaine, daidzein, hispidulin, α-linoleic acid, and 4-coumaric acid.The aqueous root extracts have high antioxidant activity with the IC50 value of 15.2 mg/ml against DPPH free radicals.The major putatively identified compounds were docked to human pancreatic α-amylase protein, to investigate theirinhibitory activities to this enzyme. The interaction between betaine, daidzein, and hispidulin in docking with humanpancreatic a-amylase showed different binding sites to the protein. In addition, the types of bonds involved weremostly hydrogen and hydrophobic bonds which show the interactions between three ligands and α-amylase. Energygenerated from docking between betaine, daidzein, and hispidulin with α-amylase was −137.6, −245.8, and −236.7cal/mol, respectively. This study concludes that the aqueous root extracts of R. tuberosa L. have prospective as aninhibitor for a-amylase protein and to be used as antidiabetic agent. Further, in vitro and in vivo studies are needed toconfirm this work.